Safety and Efficacy of Phacoemulsification with Trabecular Microbypass Stent in Glaucoma
Author Information
Author(s): Muacevic Alexander, Adler John R, Hirooka Kazuyuki, Onoe Hiromitsu, Okumichi Hideaki, Kiuchi Yoshiaki
Primary Institution: Hiroshima University
Hypothesis
Is phacoemulsification with trabecular microbypass stent implantation safe and effective for patients with primary angle-closure glaucoma?
Conclusion
Phacoemulsification with trabecular microbypass stent implantation is a safe and effective procedure for patients with primary angle-closure glaucoma.
Supporting Evidence
- Preoperative IOP ranged from 12 to 18 mmHg and postoperative IOP ranged from 9 to 17 mmHg.
- All but one patient had a decrease in the number of glaucoma medications at six months postoperatively.
- No significant complications such as hyphema or IOP spikes were observed.
Takeaway
Doctors tested a new eye surgery to help people with a specific type of glaucoma, and it worked well without causing problems.
Methodology
This prospective study evaluated PACG patients who underwent phacoemulsification with iStent inject W implantation and monitored them for 6 months.
Limitations
The study did not include a control group and had a small sample size of only 6 patients.
Participant Demographics
One male and five female patients aged 62 to 84 years.
Statistical Information
P-Value
0.51
Statistical Significance
p=0.51
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website